Author

@HedgeFundTips HedgeFundTips

Named hedge-fund PM mixing bottom-up earnings teardowns with daily breadth and money-flow data

Publishes real-time fundamental analysis of individual stock

trader score
+0.73
hit rate
70%
mean α
+0.28%
signals 14d
88

Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.

Their picks, scored

Across their last 20 scored bets: 70% hit rate, +0.28% mean alpha, trader score +0.73. Their last-14d mentions, direction-adjusted, have moved -3.4% since posting (mean over 46 mentions with price data).

Recent signals15receipts included
date (PT)tickerauthorsentwhat they saidsince thenreceipt
2026-10-15·@HedgeFundTips·States the author's framework is not positioned against the consumer.·
2026-10-14GFS@HedgeFundTips+0.10Presents a broad list of names receiving money flows today; output is capped at six tickers.-9.3%
2026-10-14LEGN@HedgeFundTips+0.10Presents a broad list of names receiving money flows today; output is capped at six tickers.+1.2%
2026-10-14HALO@HedgeFundTips+0.10Presents a broad list of names receiving money flows today; output is capped at six tickers.·
2026-10-14LQDA@HedgeFundTips+0.10Presents a broad list of names receiving money flows today; output is capped at six tickers.+25.7%
2026-10-14BSP@HedgeFundTips+0.10Presents a broad list of names receiving money flows today; output is capped at six tickers.-17.5%
2026-10-14MBLY@HedgeFundTips+0.10Presents a broad list of names receiving money flows today; output is capped at six tickers.-8.5%
2026-10-14·@HedgeFundTips·Warns that attractive thematic stories do not necessarily offer attractive prices.·
2026-10-13NTRA@HedgeFundTips+0.00Shares an equal-weight chart of biotech earnings estimates and revisions.+2.1%
2026-10-13TWST@HedgeFundTips+0.00Shares an equal-weight chart of biotech earnings estimates and revisions.-7.5%
2026-10-13MRNA@HedgeFundTips+0.00Shares an equal-weight chart of biotech earnings estimates and revisions.-7.5%
2026-10-13IOVA@HedgeFundTips+0.00Shares an equal-weight chart of biotech earnings estimates and revisions.-2.8%
2026-10-13ABBV@HedgeFundTips+0.00Shares an equal-weight chart of biotech earnings estimates and revisions.+4.1%
2026-10-13XBI@HedgeFundTips+0.00Shares an equal-weight chart of biotech earnings estimates and revisions.+1.9%
2026-10-13REGN@HedgeFundTips+0.00Shares a chart covering biotech earnings estimates and revisions.+6.9%

Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.